Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase EARLY_PHASE1 1Phase 3 1Phase 2 1

Status

Completed 3Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Dermatologic 5

Conditions

Keratosis, Actinic 5Lymphoma, T-Cell, Cutaneous 2Mycosis Fungoides 1Keratosis 1Dermatitis, Contact 1

Interventions

3-ingenyl angelate 42Aminolevulinic Acid 34Imiquimod 29Fluorouracil 23Photochemotherapy 22methyl 5-aminolevulinate 14Gels 12Diclofenac 12Cryotherapy 12tirbanibulin 7Solutions 7BF-200 ALA 6calcipotriene 5Petrolatum 5Ointments 5LEO 43204 5Radiotherapy 4Prilocaine 4Lidocaine 4Therapeutics 3Niacinamide 3Cryosurgery 3Biopsy 31-phenyl-3,3-dimethyltriazene 3Tomography, Optical Coherence 2SR-T100 2Phototherapy 2Imipramine 2Deoxyribonuclease (Pyrimidine Dimer) 2Celecoxib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Keratosis, Actinic × Ointments × Dermatologic × Clear all
NCT07137819 2025-08-22

EXACT-1

Aresus Pharma GmbH

Phase 3 Recruiting
280 enrolled
Dermatologic

Keratosis, Actinic

NCT05741294 2025-02-20

A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses

Almirall, S.A.

Phase 4 Completed
334 enrolled 12 charts
Dermatologic

Keratosis, Keratosis, Actinic

NCT05387525 2025-02-11

AKtive

Almirall, S.A.

Phase 4 Active not recruiting
447 enrolled
Dermatologic

Keratosis, Actinic

NCT03083470 2019-05-15

Study of SOR007 Ointment for Actinic Keratosis

DFB Soria, LLC

Phase 2 Completed
33 enrolled 15 charts
Dermatologic

Keratosis, Actinic

NCT02019355 2016-05-19

AK

Washington University School of Medicine

Phase EARLY_PHASE1 Completed
132 enrolled
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡